Drug Target Insights

SJR Rank #8,356H-index: 20SJR: 0.692Best quartile: Q1Open AccessAPC: US$1,617Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

AboutScience Srl

Country

Italy

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
  • Clinical BiochemistryQ2
  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Antibiotic Resistance in BacteriaPharmacological Effects of Natural CompoundsGastrointestinal motility and disordersComputational Drug Discovery MethodsDiabetes Treatment and ManagementAntibiotic Use and ResistanceNanoparticle-Based Drug DeliveryDrug Solubulity and Delivery SystemsHIV/AIDS drug development and treatmentRNA Interference and Gene Delivery

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs015304560

Documents per Year

20222025036912

Detailed Information

ISSN

1177-3928

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.52

References per Document

38.33

Coverage

2008-2009, 2011-2025

Scope

Drug Target Insights (DTI) is an international, indexed, peer-reviewed, open access, online only journal, published once a year. It covers current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life.

Metrics from SCImago Journal Rank 2025. View on SCImago